NEW YORK (GenomeWeb News) – Despite some pickup year over year in the second half of 2012, the number of acquisitions in the 'omics-related life science tools and molecular diagnostics spaces slipped 5 percent this past year compared to 2011.

In total, 55 deals were either completed or announced during the past 12 months, down from 58 deals a year ago as a surge in activity later in the year only partially offset a sluggish first half of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.